Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stirrups

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|February 26, 2019
Axitinib combination therapies versus sunitinib for renal cell carcinomaRobert Stirrups
The Lancet. Oncology|February 13, 2018
CAR T-cells for relapsed B-cell ALL in children and young adultsRobert Stirrups
The Lancet. Oncology|December 19, 2017
CAR T-cell therapy in refractory large B-cell lymphomaRobert Stirrups
The Lancet. Oncology|August 13, 2019
Ibrutinib and rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|September 4, 2019
Selinexor-dexamethasone for refractory multiple myelomaRobert Stirrups
The Lancet. Oncology|April 13, 2020
CAR T-cell therapy for relapsed or refractory mantle-cell lymphomaRobert Stirrups
The Lancet. Oncology|August 14, 2018
HPV status and oesophageal adenocarcinomaRobert Stirrups
The Lancet. Oncology|May 16, 2018
Chemoradiotherapy for pancreatic adenocarcinomaRobert Stirrups
The Lancet. Neurology|September 20, 2024
Navigating the roads ahead for Alzheimer's diseaseRobert Stirrups
The Lancet. Oncology|February 4, 2018
HIPEC improves survival in stage III epithelial ovarian cancerRobert Stirrups
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|February 26, 2019
Axitinib combination therapies versus sunitinib for renal cell carcinomaRobert Stirrups
The Lancet. Oncology|February 13, 2018
CAR T-cells for relapsed B-cell ALL in children and young adultsRobert Stirrups
The Lancet. Oncology|December 19, 2017
CAR T-cell therapy in refractory large B-cell lymphomaRobert Stirrups
The Lancet. Oncology|August 13, 2019
Ibrutinib and rituximab for chronic lymphocytic leukaemiaRobert Stirrups
The Lancet. Oncology|September 4, 2019
Selinexor-dexamethasone for refractory multiple myelomaRobert Stirrups
The Lancet. Oncology|April 13, 2020
CAR T-cell therapy for relapsed or refractory mantle-cell lymphomaRobert Stirrups
The Lancet. Oncology|August 14, 2018
HPV status and oesophageal adenocarcinomaRobert Stirrups
The Lancet. Oncology|May 16, 2018
Chemoradiotherapy for pancreatic adenocarcinomaRobert Stirrups
The Lancet. Neurology|September 20, 2024
Navigating the roads ahead for Alzheimer's diseaseRobert Stirrups
The Lancet. Oncology|February 4, 2018
HIPEC improves survival in stage III epithelial ovarian cancerRobert Stirrups
Pageof 5